Morning Briefing
Summaries of health policy coverage from major news organizations
Appointment Of Drug Company To GAVI Board Draws Criticism From NGOs
The appointment of Dutch pharmaceutical company Crucell, recently acquired by Johnson & Johnson, to the board of the GAVI Alliance is "sparking concerns over conflicts of interest and demands for tougher competition to reduce prices," the Financial Times reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
